Background illustration for clinical trials search

Paid Clinical Trials San Antonio

Discover 994 paid clinical trials in San Antonio, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

for
Cancer, Advanced Cancer, Locally Advanced Carcinoma,
Location: San Antonio TX, Houston TX, St Louis MO, Nashville TN,
Sponsor: Angiex, Inc.

Sex: All

Age: 18+

Code: NCT06440005

Phase 1, Recruiting

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: San Antonio TX, Houston TX, Irving TX, Scottsdale AZ,
Sponsor: Tagworks Pharmaceuticals BV

Sex: All

Age: 18+

Code: NCT06959706

Phase 1, Recruiting

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

for
Advanced Solid Tumor, Advanced Breast Cancer,
Location: San Antonio TX, Houston TX, Irving TX, Denver CO,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06120283

Phase 1, Recruiting

A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2

for
Metastatic Malignant Neoplasm
Location: San Antonio TX, Houston TX, Fairfax VA, Baltimore MD,
Sponsor: NextPoint Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06240728

Phase 1, Recruiting

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: San Antonio TX, Austin TX, Houston TX, Dallas TX,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT05379985

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: San Antonio TX, Houston TX, Irving TX, Aurora CO,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06384352

Phase 1, Recruiting

A Study of ASP3082 in Adults With Advanced Solid Tumors

for
Solid Tumor
Location: San Antonio TX, Westwood KS, St Louis MO, Denver CO,
Sponsor: Astellas Pharma Inc

Sex: All

Age: 18+

Code: NCT05382559

Phase 1, Recruiting

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

for
KRAS G12C Mutation, KRAS G12S Mutation,
Location: San Antonio TX, Oklahoma City OK, Denver CO, Phoenix AZ,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT06720987

Phase 1, Recruiting

A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.

for
Advanced Solid Tumors
Location: San Antonio TX, Houston TX, Denver CO, Lake Mary FL,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06907043

Phase 1, Phase 2, Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

for
Advanced Solid Tumor, Advanced Malignant Neoplasm,
Location: San Antonio TX, Austin TX, Houston TX, Dallas TX,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 12+

Code: NCT04585750

Phase 1, Phase 2, Recruiting

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

for
Cancer, Tumor, Solid, Malignant Neoplasm, Metastatic Cancer,
Location: San Antonio TX, Austin TX, Irving TX, Fairfax VA
Sponsor: OncoResponse, Inc.

Sex: All

Age: 18+

Code: NCT06090266

Phase 1, Phase 2, Recruiting

Cognitive Screening Made Easy for PCPs - Administrative Supplement

for
Cognitive Impairment, Cognitive Decline, Dementia, Mild
Location: San Antonio TX, Austin TX
Sponsor: University of Texas at Austin

Sex: All

Age: 60+

Code: NCT06928298

Recruiting

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

for
Crohn Disease, Colitis, Ulcerative
Location: San Antonio TX, Southlake TX, Garland TX, Tyler TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0+

Code: NCT06651281

Phase 3, Recruiting

An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection

for
Clostridium Difficile (C. Difficile)
Location: San Antonio TX, Idaho Falls ID, Butte MT, Sacramento CA,
Sponsor: Deinove

Sex: All

Age: 18+

Code: NCT03988855

Phase 2, Recruiting

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

for
Crohn's Disease
Location: San Antonio TX, Tyler TX, Colorado Springs CO, Toronto,
Sponsor: Takeda

Sex: All

Age: 18 - 65

Code: NCT06227910

Phase 3, Recruiting

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

for
Asthma
Location: San Antonio TX, Houston TX, Dallas TX, Oklahoma City OK,
Sponsor: AstraZeneca

Sex: All

Age: 5 - 11

Code: NCT06023589

Phase 3, Recruiting

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

for
Colitis, Ulcerative
Location: San Antonio TX, Tyler TX, Lafayette LA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07577856

Phase 3, Recruiting

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

for
Crohn Disease
Location: San Antonio TX, Kingwood TX, Topeka KS, St Louis MO,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07483099

Phase 2, Recruiting

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

for
Colitis, Ulcerative, Crohn Disease
Location: San Antonio TX, Kingwood TX, Topeka KS, St Louis MO,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07483073

Phase 2, Recruiting

A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)

for
Irritable Bowel Syndrome, Constipation
Location: San Antonio TX, Webster TX, McAllen TX, Mesa AZ,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07545772

Phase 2, Recruiting

With a robust healthcare network and several renowned medical research institutions, San Antonio is a key hub for clinical research. Leading organizations such as UT Health San Antonio, Brooke Army Medical Center, and the Texas Biomedical Research Institute are at the forefront of groundbreaking studies.

These institutions are recognized for their expertise in areas like cancer, infectious diseases, trauma care, and military health, positioning San Antonio as an important city in advancing medical research and improving patient outcomes.

Why choose San Antonio for clinical trials?

For those keen to participate in clinical trials, San Antonio offers distinct advantages. The city’s diverse population provides a wide range of participants, making research findings more reliable and applicable across various demographics.

By joining a clinical trial in San Antonio, participants not only gain access to cutting-edge treatments but also contribute to critical advancements in medical research. The city’s well-established research infrastructure and supportive medical community ensure high-quality care and valuable contributions.

Common conditions studied in San Antonio

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in San Antonio